Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer

Annals of Surgical Oncology

Volumn 20, Issue 3, 2013, Pages 864-871

  Restivo, Angelo ^a   Zorcolo, Luigi ^a   Cocco, Ivana Maria Francesca ^a   Manunza, Romina ^a   Margiani, Carla ^a   Marongiu, Luigi ^a   Casula, Giuseppe ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGE DISTRIBUTION; AGED; ANAL VERGE; ANUS SPHINCTER; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CHEMORADIOTHERAPY; COMPLETE PATHOLOGICAL RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARAMETERS; PREDICTOR VARIABLE; RECTUM CANCER; RECTUM SURGERY; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TOTAL MESORECTAL EXCISION; TREATMENT RESPONSE;

AGED; ANAL CANAL; CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84875224033     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2669-8     Document Type: Article

References (46)

1. E Kapiteijn CA Marijnen ID Nagtegaal H Putter WH Steup T Wiggers, et al. 2001 Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med. 345 638 646 11547717 10.1056/NEJMoa010580 1:STN:280:DC%2BD3Mvps1ektw%3D%3D
2. L Pahlman B Glimelius 1990 Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial Ann Surg. 211 187 195 2405793 10.1097/00000658-199002000-00011 1:STN:280: DyaK3c7ks1GisA%3D%3D
3. R Sauer H Becker W Hohenberger C Rödel C Wittekind R Fietkau, et al. 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med. 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528: DC%2BD2cXovFSksbo%3D
4. MRCRC Working Party 1996 Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party Lancet. 348 1605 1610 10.1016/S0140-6736(96)05348-2
5. CH Crane JM Skibber BW Feig JN Vauthey HD Thames SA Curley, et al. 2003 Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma Cancer. 97 517 524 12518377 10.1002/cncr.11075
6. H Quah J Chou M Gonen J Shia D Schrag LB Saltz, et al. 2008 Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Cancer. 113 57 64 18442099 10.1002/cncr.23516
7. C Rodel P Martus T Papadoupolos L Fuzesi M Klimpfinger R Fietkau, et al. 2005 Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol. 23 8688 8696 16246976 10.1200/JCO.2005.02.1329
8. MS Roh LH Colangelo MJ O'Connell G Yothers M Deutsch CJ Allegra, et al. 2009 Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol. 27 5124 5130 19770376 10.1200/JCO.2009.22.0467
9. F Stipa D Chessin J Shia PB Paty M Weiser LK Temple, et al. 2006 A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography Ann Surg Oncol. 13 1047 1053 16865595 10.1245/ASO.2006.03.053
10. C Aschele ML Friso S Pucciarelli S Lonardi L Sartor G Fabris, et al. 2005 A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol. 16 1140 1146 15894548 10.1093/annonc/mdi212 1:STN:280:DC%2BD2MzhsFSjtA%3D%3D
11. C Carlomagno A Farella L Bucci FP D'Armiento G Pesce S Pepe, et al. 2009 Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study Ann Oncol. 20 906 912 19155242 10.1093/annonc/mdn719 1:STN:280:DC%2BD1MzgvVygug%3D%3D
12. P Das J Skibber M Rodriguez-Bigas BW Feig GJ Chang RA Wolff, et al. 2007 Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer Cancer. 109 1750 1755 17387743 10.1002/cncr.22625 1:CAS:528:DC%2BD2sXlsF2ntbg%3D
13. S Pucciarelli C Capirci U Emanuele P Toppan ML Friso GM Pennelli, et al. 2005 Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer Ann Surg Oncol. 12 111 116 15827790 10.1245/ASO.2005.03.044
14. TE Read MS McNevin EK Gross HM Whiteford JL Lewis G Ratkin, et al. 2001 Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity Dis Colon Rectum. 44 513 522 11330578 10.1007/BF02234323 1:STN:280:DC%2BD3M3jvVGgtg%3D%3D
15. R Rengan PB Paty WD Wong JG Guillem M Weiser L Temple, et al. 2006 Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders Clin Colorectal Cancer. 5 413 421 16635280 10.3816/CCC.2006.n.012
16. C Rodel T Liersch RM Hermann D Arnold T Reese M Hipp, et al. 2007 Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer J Clin Oncol. 25 110 117 17194912 10.1200/JCO.2006.08.3675
17. DI Rosenthal PJ Catalano DG Haller JC Landry ER Sigurdson FR Spitz, et al. 2008 Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297 Int J Radiat Oncol Biol Phys. 72 108 113 18722265 10.1016/j.ijrobp.2008.05.054 1:CAS:528:DC%2BD1cXhtVamu77I
18. AT Shivnani W Small Jr SJ Stryker KD Kiel S Lim AL Halverson, et al. 2007 Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors Am J Surg. 193 389 393 17320541 10.1016/j.amjsurg.2006.09.030 discussion 393-4
19. M Kalady LF de Campos-Lobato L Stocchi DP Geisler D Dietz IC Lavery, et al. 2009 Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg. 250 582 589 19710605
20. M Kikuchi T Mikami T Sato W Tokuyama K Araki M Watanabe, et al. 2009 High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction Br J Cancer. 101 116 123 19491899 10.1038/sj.bjc.6605105 1:CAS:528:DC%2BD1MXotVKguro%3D
21. IJ Kim S Lim HC Kang HJ Chang SA Ahn HW Park, et al. 2007 Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer Dis Colon Rectum. 50 1342 1353 17665260 10.1007/s10350-007-277-7
22. FV Negri N Campanini R Camisa F Pucci S Bui G Ceccon, et al. 2008 Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy Br J Cancer. 98 143 147 18087284 10.1038/sj.bjc.6604131 1:CAS:528:DC%2BD1cXisF2rtg%3D%3D
23. K Bujko MP Nowacki A Nasierowska-Guttmejer W Michalski M Bebenek M Pudełko, et al. 2004 Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol. 72 15 24 15236870 10.1016/j.radonc.2003.12.006 1:STN:280:DC%2BD2czpsVSmsQ%3D%3D
24. Y Francois CJ Nemoz J Baulieux J Vignal JP Grandjean C Partensky, et al. 1999 Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial J Clin Oncol. 17 2396 10561302 1:STN:280:DC%2BD3c%2FjtVSgsw%3D%3D
25. L Zorcolo G Fantola F Cabras L Marongiu G D'Alia G Casula 2009 Preoperative staging of patients with rectal tumors suitable for transanal endoscopic microsurgery (TEM): comparison of endorectal ultrasound and histopathologic findings Surg Endosc. 23 1384 1389 19263149 10.1007/s00464-009- 0349-y
26. YA Park SK Sohn J Seong SH Baik KY Lee NK Kim, et al. 2006 Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer J Surg Oncol. 93 145 150 16425302 10.1002/jso.20320
27. SM Yoon D Kim TH Kim KH Jung HJ Chang WS Koom, et al. 2007 Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer Int J Radiat Oncol Biol Phys. 69 1167 1172 17967307 10.1016/j.ijrobp.2007.04.047
28. RO Perez GP São Julião A Habr-Gama D Kiss I Proscurshim FG Campos, et al. 2009 The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer Dis Colon Rectum. 52 1137 1143 19581858 10.1007/DCR.0b013e31819ef76b
29. RA Haward E Morris JR Monson C Johnston D Forman 2005 The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study Eur J Surg Oncol. 31 22 28 15642422 10.1016/j.ejso.2004.08.002 1:STN:280:DC%2BD2M%2Fhs1Kmtw%3D%3D
30. R Marr K Birbeck J Garvican CP Macklin NJ Tiffin WJ Parsons, et al. 2005 The modern abdominoperineal excision: the next challenge after total mesorectal excision Ann Surg. 242 74 82 15973104 10.1097/01.sla.0000167926.60908.15
31. M den Dulk H Putter L Collette CA Marijnen J Folkesson JF Bosset, et al. 2009 The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer Eur J Cancer. 45 1175 1183 10.1016/j.ejca.2008.11.039
32. J Guillem D Chessin J Shia A Suriawinata E Riedel HG Moore, et al. 2007 A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy Ann Surg. 245 88 93 17197970 10.1097/01.sla.0000232540.82364.43
33. K Peeters C Marijnen I Nagtegaal EK Kranenbarg H Putter T Wiggers, et al. 2007 The TME trial after a median follow-up of 6 years Ann Surg. 246 693 701 17968156 10.1097/01.sla.0000257358.56863.ce
34. JH Lee SH Kim J-G Kim HM Cho BY Shim 2011 Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes Int J Radiat Oncol Biol Phys. 81 431 438 20732756 10.1016/j.ijrobp.2010.05.019
35. L Moureau-Zabotto B Farnault C Chaisemartin B Esterni B Lelong F Viret, et al. 2011 Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer Int J Radiat Oncol Biol Phys. 80 483 491 21093174 10.1016/j.ijrobp.2010.02.025
36. C Aschele L Cionini S Lonardi C Pinto S Cordio G Rosati, et al. 2011 Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol. 29 2773 2780 21606427 10.1200/JCO.2010.34.4911 1:CAS:528:DC%2BC3MXhtVOnur%2FI
37. J-P Gerard D Azria S Gourgou-Bourgade I Martel-Laffay C Hennequin PL Etienne, et al. 2010 Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol. 28 1638 1644 20194850 10.1200/JCO.2009.25.8376 1:CAS:528:DC%2BC3cXmtVyhur0%3D
38. C Weiss D Arnold K Dellas T Liersch M Hipp R Fietkau, et al. 2010 Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: a pooled analysis of three prospective phase I-II trials Int J Radiat Oncol Biol Phys. 78 472 478 20133081 10.1016/j.ijrobp.2009.07.1718 1:CAS:528:DC%2BC3cXhtFCmtLnI
39. H Tulchinsky E Shmueli A Figer J Klausner M Rabau 2008 An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol. 15 2661 2667 18389322 10.1245/s10434-008-9892-3
40. S Supiot J Bennouna E Rio G Meurette E Bardet B Buecher, et al. 2006 Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer Colorectal Dis. 8 430 435 16684088 10.1111/j.1463-1318.2006.00990.x 1:STN:280:DC%2BD283lvF2htw%3D%3D
41. KM Bullard JL Trudel NN Baxter DA Rothenberger 2005 Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure Dis Colon Rectum. 48 438 443 15719190 10.1007/s10350-004-0827-1
42. KL Mathis DW Larson EJ Dozois RR Cima M Huebner MG Haddock, et al. 2012 Outcomes following surgery without radiotherapy for rectal cancer Br J Surg. 99 137 143 22052336 10.1002/bjs.7739 1:STN:280:DC%2BC38%2FktF2isQ%3D%3D
43. P Luna-Perez EL Arriola Y Cuadra I Alvarado A Quintero 1998 p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma Ann Surg Oncol. 5 203 208 9607618 10.1007/BF02303772 1:STN:280:DyaK1c3mvVKgtg%3D%3D
44. G Esposito S Pucciarelli R Alaggio L Giacomelli E Marchiori GA Iaderosa, et al. 2001 P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer Ann Surg Oncol. 8 311 318 11352304 10.1007/s10434-001-0311-2 1:STN:280:DC%2BD3M3lsVWguw%3D%3D
45. FR Spitz GG Giacco K Hess L Larry TA Rich N Janjan, et al. 1997 p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer Clin Cancer Res. 3 1685 1690 9815551 1:STN:280:DyaK1M7htFWjuw%3D%3D
46. JG Kuremsky JE Tepper HL McLeod 2009 Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys. 74 673 688 19480968 10.1016/j.ijrobp.2009.03.003 1:CAS:528:DC%2BD1MXmsFyiu7g%3D